Yo-El Ju

On the other hand, I do know that it, you know, some people say it has really helped them.

So I say, if it helps you and it doesn't harm you, go ahead.

Yeah, and it is especially so for insomnia.

It's great and it's also not great for clinical trials.

But, you know, seeing a half hour or even 40 minutes of increased total sleep time on objective polysomnography is very common in insomnia drug trials.

So I think that in general, we should be cautious in having people take drugs to increase their sleep because I think the best sleep is the kind that people can get on their own.

So most people's brains have the ability to fall asleep every night.

So if people are having problems sleeping where they're asking for medication to help with their sleep,

I think sometimes we kind of, or in medical practice, we can jump to giving the drug without maybe looking for why people are having problems sleeping.

Sleep disorders are extremely common.

For example, sleep apnea, probably, you know, 20, 30% of them.

American population, middle-aged or older, has sleep apnea.

But, you know, most doctors who prescribe, say, Ambien or any of the sleep drugs probably are not screening for and testing for sleep apnea or other sleep disorders before they prescribe them.

So I think we do need to be cautious about, well, who are these people who are taking medications, right?

So do they have a sleep disorder?

Do they have some other reason to be having the sleep problems in the first place?

So it may not necessarily be the drug.

It could be whatever is going on that is causing them to want or need the sleep drug in the first place.

I don't think necessarily the NBBRase, you know, the class of drugs that zolpidem is in, I don't think that they're necessarily bad.

You know, I prescribe it in a small number of patients if it's appropriate.